Manufacturers of high-potency active pharmaceutical ingredients (HPAPIs) with specialized containment and handling capabilities for potent compounds. HPAPI manufacturing requires containment strategies including isolator technology, closed-system transfer, continuous monitoring of occupational exposure limits (OELs), and dedicated HVAC with HEPA filtration to prevent cross-contamination. Peptide HPAPIs include cytotoxic peptides for oncology, ADC payloads requiring sub-milligram handling precision, and hormonal peptides with activity at nanomolar concentrations. Facility design for peptide HPAPI production follows ICH Q7 GMP guidelines with additional containment requirements per ISPE Good Practice Guide on HPAPI handling. Showing 10 listed suppliers.
Our directory lists suppliers offering hpapis services across North America, Asia, Europe regions. Supplier types include CDMO. Browse individual profiles below for detailed capability information, manufacturing standards, and quality documentation.
Directory listing last reviewed July 2026.